Latest News

ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.

Read More

​ ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023. ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.  Moneycontrol Latest News Read More  

ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.

ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.

Read More

​ ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023. ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.  Moneycontrol Latest News Read More  

ICICI Direct recommended hold rating on HCL Technologies with a target price of Rs 1119 in its research report dated January 16, 2023.

The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence

Read More

​ The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence  Moneycontrol Latest News Read More  

The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence

The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence

Read More

​ The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence  Moneycontrol Latest News Read More  

The World Economic Forum interacted with three chief economists to find out how business leaders can best prepare their organisations to weather the economic storms ahead. The World Economic Forum Chief Economists Outlook, January 2023, reveals how businesses can prepare for the looming turbulence

The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing.

Read More

​ The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing. The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing.  Moneycontrol Latest News Read More  

The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing.

FY 2026-27, the company expects the size of the new bus market to grow to 80,000 to 90,000 units per annum and 50 percent of them to be pure electric vehicles

Read More

​ FY 2026-27, the company expects the size of the new bus market to grow to 80,000 to 90,000 units per annum and 50 percent of them to be pure electric vehicles FY 2026-27, the company expects the size of the new bus market to grow to 80,000 to 90,000 units per annum and 50 percent of them to be pure electric vehicles  Moneycontrol Latest News Read More  

FY 2026-27, the company expects the size of the new bus market to grow to 80,000 to 90,000 units per annum and 50 percent of them to be pure electric vehicles

Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period

Read More

​ Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period  Moneycontrol Latest News Read More  

Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period

Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period

Read More

​ Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period  Moneycontrol Latest News Read More  

Bank of Maharashtra Q3: The public sector lender#39;s net profit came in at Rs 775 crore, up from Rs 324.6 crore in the year-ago period

On an average Indian super rich own 5.1 residential properties compared to the global average of 4.2 units

Read More

​ On an average Indian super rich own 5.1 residential properties compared to the global average of 4.2 units On an average Indian super rich own 5.1 residential properties compared to the global average of 4.2 units  Moneycontrol Latest News Read More  

On an average Indian super rich own 5.1 residential properties compared to the global average of 4.2 units

At the same time, the number of unemployed people in the world is expected to rise by 3 million to 208 million in 2023, while inflation will eat into real wages, the ILO said in a report on global trends.

Read More

​ At the same time, the number of unemployed people in the world is expected to rise by 3 million to 208 million in 2023, while inflation will eat into real wages, the ILO said in a report on global trends. At the same time, the number of unemployed people in the world is expected to rise by 3 million to 208 million in 2023, while inflation will eat into real wages, the ILO said in a report on global trends.  Moneycontrol Latest News Read More  

At the same time, the number of unemployed people in the world is expected to rise by 3 million to 208 million in 2023, while inflation will eat into real wages, the ILO said in a report on global trends.